Pharmaceutical

Pelvic floor muscle training a safer treatment than transvaginal mesh

Pelvic floor muscle training should be the first line of treatment for female stress urinary incontinence (SUI) and pelvic organ prolapse (POP), because it shows promising results in clinical studies with virtually no adverse side effects, according to the Norwegian School of Sports Sciences in Oslo, Norway.

According to randomized controlled trials, pelvic floor muscle training, or PFM training, was shown to be an effective treatment in SUI by as much as 35 to 80 percent in the short-term. Furthermore, there are five such trials showing a significant effect of PFM training on either POP stage, symptoms or PFM morphology, researchers said. There are, however, no clinical trials addressing the effects of PFM training on sexual dysfunction associated with POP.

Supervised training of pelvic floor muscle strengthening exercises and more intensive training was proven to be more effective than unsupervised training. Plus, the practice showed no adverse effects, which is promising considering a conventional treatment for the disorders is currently under a review by the Food and Drug Administration (FDA).

Both stress urinary incontinence and pelvic organ prolapse are often treated by the transvaginal insertion of surgical mesh, also known as transvaginal mesh. In July, the FDA issued an alert about the surgical mesh used in this manner, stating that reports showed that complications were “not rare” and that patients who received the mesh, in particular for pelvic organ prolapse repair, may be exposed to greater risks with no added benefits.

Source: Uro Today